Biotech Values

[mcbio]

ASMB:

$asmb says to stay tuned, expecting antigen declines to follow. personally wouldnt bet money on it. cc @BagholderQuotes pic.twitter.com/iVWvPkUKkP

— Dirk Haussecker (@RNAiAnalyst) April 13, 2019

https://twitter.com/jsksrs/status/1117111445295128576

Yep, have to agree with Julia that seems likely that ASMB shares probably won't open nicely on Monday. Would be surprised if they don't end up down on the day given the disappointment with the HBsAg declines. Certainly seemed pretty obvious that the announcement of the 4th and 5th CpAMs to come foreshadowed this disappointing data with the lead drug. One other thing I didn't mention on my prior notes beyond the additional CpAM candidates was that the CEO pretty clearly hinted that this would be early data and stressed the need for more mature data. That was another pretty clear hint that this data would be disappointing.

Guess remains to be seen if 48-week data will look any better for the lead on HBsAg declines but, given all these follow-on drugs, I'm just going to continue to remain skeptical.